Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Louisiana seeks California doctor’s extradition, testing the limits of shield laws - 2Consumer outlook on UK economy falls to two-year low
- 3Watch SpaceX launch powerful ocean-mapping satellite for Europe and NASA early Nov. 17
- 4Korean Air takes emergency action as fuel prices soar
- 5Trump signs bill allowing whole milk to return to school lunches
- Why is Jerome Powell being investigated? Making sense of the DOJ's probe into the Federal Reserve chair.
- Malaysia To Revive Search for Missing Flight MH370
- Coalition led by Iraqi PM al-Sudani wins parliamentary elections
- Role reversal: Ukraine moves training home and exports the lessons abroad
- Step by step instructions to Protect Your Speculations with Cd Rates
- What's inside Mexico's Popocatépetl? Scientists obtain first 3D images of the whole volcano
- Thousands of ultra-orthodox protest in Jerusalem against conscription
- How to watch 'A Charlie Brown Christmas' for less with this Apple TV Black Friday deal
- How comfort foods trigger pleasure in our brains
